A Phase 1, Open Label, Single Sequence, Two-Way Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1379572 Pharmacokinetics in Healthy Adult Subjects
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 05 Jan 2015
At a glance
- Drugs Dolutegravir (Primary) ; Fosdevirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; ViiV Healthcare
- 26 Oct 2014 Status changed from suspended to withdrawn prior to enrolment, as per ClinicalTrials.gov record.
- 11 Mar 2011 Actual initiation date (Mar 2011) added as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.